Type 2 Diabetes Mellitus Clinical Trial
Official title:
Physical Activity for Overweight Youth at Risk for Type 2 Diabetes Mellitus (POWER) Trial
Background:
The investigators know that exercise helps children develop strong bones and muscles and
generally stay healthy. What is unclear however, is how much exercise a child needs to lower
their risk of developing type 2 diabetes.
Objective:
The investigators will try to find out whether high-intensity exercise for a short-period of
time is better than moderately intense exercise for improving the diabetes risk profile in
teens who are at risk for type 2 diabetes.
The working hypothesis is that exercise-mediated improvements in insulin sensitivity (a risk
factor for diabetes) will be greater following vigorous intermittent physical activity than
following low intensity physical activity in overweight adolescents 13-18 yrs at risk for
T2DM.
Brief Description of Research Project: Teenagers between the ages of 13 and 18 yrs, who are
at risk for type 2 diabetes (either by their family history or an abnormal response to
sugar) will be randomly assigned to one of two activity groups or a control group. The
activity groups will have supervised exercise sessions 3 to 5 days per week for 6 months.
One group will do high-intensity exercise, and the other will do lower-intensity exercise.
We will measure how sensitive their body is to insulin and the amount of fat in their muscle
and liver tissue at the beginning and end of the exercise intervention.
The Physical activity for OverWEight youth at Risk for type 2 diabetes (POWER) Trial is a
randomized controlled clinical trial designed to study the effects of aerobic exercise
training regimens differing in intensity (relative to peak fitness) on insulin sensitivity
in overweight youth. Additionally, this trial will explore the biologic mechanisms through
which chronic physical activity alters lipid metabolism to result in improvements in insulin
sensitivity.
We will recruit 90 eligible adolescents and randomly assign them to one of two six-month
intervention arms that differ by intensity but elicit similar amounts of energy expenditure:
(1) a low intensity continuous activity arm (40-55% of peak oxygen uptake for 60 min); (2)
vigorous intensity intermittent activity arm (70-85% of peak oxygen uptake for 30 min) or a
sedentary control group. The primary outcome measure of this trial will be insulin
sensitivity, measured directly from Bergman's frequently sampled intravenous glucose
tolerance test.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |